Does Anthem cover Wegovy, Zepbound and Ozempic?
The short answer
For Anthem Blue Cross Medi-Cal (California Medicaid) members, Anthem doesn't cover Wegovy, Zepbound or Saxenda for weight loss. Anthem's notice to providers says that from January 1, 2026 these drugs are no longer eligible for coverage for weight loss under Medi-Cal Rx. Ozempic and Mounjaro stay covered with a type 2 diabetes diagnosis. If you have a commercial or employer plan, ask Anthem for your plan's formulary.
Key takeaways
- On Anthem Blue Cross Medi-Cal, Wegovy, Zepbound and Saxenda aren't covered for weight loss from January 1, 2026.
- Medi-Cal requests are still considered for Wegovy for noncirrhotic MASH or cardiovascular disease, and Zepbound for obstructive sleep apnea.
- On Medi-Cal, Ozempic and Mounjaro stay covered with a type 2 diabetes diagnosis, but not for weight loss.
- Medi-Cal members under 21 can ask their prescriber to submit a weight-loss request for medical necessity review.
- On a commercial or employer Anthem plan, ask Anthem for your formulary. This page doesn't cover those plans.
What the published policies say
Anthem Blue Cross (California Medi-Cal): Mounjaro medicaid-managed covered
Anthem told its California Medi-Cal providers that Mounjaro stays on the Medi-Cal Rx Contract Drugs List with a diagnosis restriction of type 2 diabetes. From January 1, 2026 it is not eligible for coverage for weight loss, and claims without the required diagnosis are rejected.
- Diagnosis of type 2 diabetes required
- Not eligible for coverage for weight loss
- Prior authorization requests for other non-weight-loss uses are reviewed for medical necessity
The following GLP-1 drugs are currently on the CDL and will continue to have a Code I diagnosis restriction of type 2 diabetes.
Anthem Blue Cross (California Medi-Cal): Ozempic medicaid-managed covered
Anthem told its California Medi-Cal providers that Ozempic stays on the Medi-Cal Rx Contract Drugs List with a diagnosis restriction of type 2 diabetes. From January 1, 2026 it is not eligible for coverage for weight loss, and claims without the required diagnosis are rejected.
- Diagnosis of type 2 diabetes required
- Not eligible for coverage for weight loss
- Prior authorization requests for other non-weight-loss uses are reviewed for medical necessity
The following GLP-1 drugs are currently on the CDL and will continue to have a Code I diagnosis restriction of type 2 diabetes.
Anthem Blue Cross (California Medi-Cal): Saxenda medicaid-managed not covered
Anthem told its California Medi-Cal providers that from January 1, 2026 Saxenda is removed from the Medi-Cal Rx Contract Drugs List and is no longer eligible for coverage for weight loss. Claims are rejected and earlier prior authorizations expire. Requests for members under 21 are reviewed under the federal EPSDT benefit.
- Not covered for weight loss from January 1, 2026
- Previously approved prior authorizations expire
- Members under 21: weight-loss requests reviewed for medical necessity under EPSDT
Effective January 1, 2026, these drugs will be removed from the CDL and will no longer be eligible for coverage for weight loss or weight-loss indications:
Anthem Blue Cross (California Medi-Cal): Wegovy medicaid-managed not covered
Anthem told its California Medi-Cal providers that from January 1, 2026 Wegovy is no longer eligible for coverage for weight loss under Medi-Cal Rx. Prior authorization requests are still considered when Wegovy is used for MASH or cardiovascular disease, and for members under 21 under the federal EPSDT benefit.
- Not covered for weight loss from January 1, 2026
- Prior authorization considered for MASH or cardiovascular disease
- Members under 21: weight-loss requests reviewed for medical necessity under EPSDT
Effective January 1, 2026, these drugs will be removed from the CDL and will no longer be eligible for coverage for weight loss or weight-loss indications: ... Wegovy when used for noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) or cardiovascular disease
Anthem Blue Cross (California Medi-Cal): Zepbound medicaid-managed not covered
Anthem told its California Medi-Cal providers that from January 1, 2026 Zepbound is no longer eligible for coverage for weight loss under Medi-Cal Rx. Prior authorization requests are still considered when Zepbound is used for obstructive sleep apnea, and for members under 21 under the federal EPSDT benefit.
- Not covered for weight loss from January 1, 2026
- Prior authorization considered for obstructive sleep apnea
- Members under 21: weight-loss requests reviewed for medical necessity under EPSDT
Effective January 1, 2026, these drugs will be removed from the CDL and will no longer be eligible for coverage for weight loss or weight-loss indications: ... Zepbound when used for obstructive sleep apnea (OSA)
Policies differ between plans from the same insurer and change during the year. Your own plan documents decide.
Anthem is a large insurer with commercial, Medicare and Medicaid plans in many states. Our records contain one Anthem document, and it’s narrow: a notice from Anthem Blue Cross to its California Medi-Cal managed care providers, titled “GLP-1 Coverage Considerations.”
The rest of this page is for Medi-Cal members whose plan is Anthem Blue Cross.
What changed on January 1, 2026
Medi-Cal’s pharmacy benefit runs through Medi-Cal Rx and its Contract Drugs List (CDL), the list of drugs it covers. Anthem’s notice to providers says: “Effective January 1, 2026, these drugs will be removed from the CDL and will no longer be eligible for coverage for weight loss or weight-loss indications.”
For the three weight-loss medicines in our records, that means:
- Wegovy: not covered for weight loss.
- Zepbound: not covered for weight loss.
- Saxenda: removed from the Contract Drugs List and not covered for weight loss. Claims are rejected, and prior authorizations approved earlier expire.
The uses that can still be requested
The notice keeps a route open for approved uses other than weight loss. Prior authorization (the plan’s approval before it pays) is still considered for:
- Wegovy, when used for noncirrhotic MASH or cardiovascular disease.
- Zepbound, when used for obstructive sleep apnea.
A request under one of these routes has to be for that condition, with the diagnosis documented. Your prescriber decides whether one applies to you.
Members under 21
Federal Medicaid law gives members under 21 a benefit called EPSDT. Anthem’s notice says weight-loss requests for these members are reviewed for medical necessity under it. That applies to Wegovy, Zepbound and Saxenda requests alike.
Ozempic and Mounjaro
These two stay on the Contract Drugs List. The notice says they “will continue to have a Code I diagnosis restriction of type 2 diabetes.” In practice, a claim needs the type 2 diabetes diagnosis attached, and claims without it are rejected. Neither drug is eligible for coverage for weight loss. Requests for other uses that aren’t weight loss are reviewed for medical necessity through prior authorization.
What Medi-Cal members can do
- Check whether a non-weight-loss use applies. Ask your prescriber whether your records support a request for one of the uses listed above.
- If you’re under 21, ask your prescriber to submit the request for medical necessity review.
- If a request is denied, the denial notice explains how to ask for a review. Our general guide to appealing a denial and the appeal letter generator can help you prepare. A rule that removes a drug from coverage for weight loss is different from a denial on clinical grounds, and an appeal is strongest when it’s about a covered use.
- Know that savings cards are closed to you. Manufacturer savings cards exclude people enrolled in Medicaid and other government programs.
- Look at self-pay prices carefully. The manufacturers’ cash programs start at $149 a month for Wegovy and $299 for Zepbound. Read each program’s eligibility terms before you rely on one. The without-insurance guide sets them out.
To see how Medicaid coverage of these medicines works across states, read Medicaid coverage of GLP-1s. For commercial insurers, see the insurance guide.
Frequently asked questions
Does Anthem cover Wegovy for weight loss?
If you're an Anthem Blue Cross Medi-Cal member in California, no. Anthem told its Medi-Cal providers that from January 1, 2026 Wegovy is no longer eligible for coverage for weight loss under Medi-Cal Rx. If you're on one of Anthem's commercial or employer plans, ask Anthem for your plan's formulary and criteria.
Does Anthem Medi-Cal cover Zepbound for sleep apnea?
A request can be considered. Anthem's notice says prior authorization requests are still considered when Zepbound is used for obstructive sleep apnea. For weight loss, Zepbound is no longer eligible for coverage from January 1, 2026. Considered doesn't mean approved. The request is reviewed for the use it names.
Does Anthem Medi-Cal cover Ozempic?
Yes, with a diagnosis restriction. Anthem's notice says Ozempic and Mounjaro stay on the Medi-Cal Rx Contract Drugs List with a diagnosis restriction of type 2 diabetes. They aren't eligible for coverage for weight loss, and claims without the required diagnosis are rejected.
I am under 21 on Anthem Medi-Cal. Can I still get Wegovy?
Possibly. Anthem's notice says weight-loss requests for members under 21 are reviewed for medical necessity under the federal EPSDT benefit. Your prescriber submits the request with the clinical details, and the decision is made on review. It's not an automatic approval.
What happened to my existing Saxenda approval on Anthem Medi-Cal?
According to Anthem's notice, Saxenda was removed from the Medi-Cal Rx Contract Drugs List on January 1, 2026. Claims are rejected, and prior authorizations approved earlier expire. Ask your prescriber about the options that remain, including a medical necessity review if you're under 21.
Sources (6)
- 1.Anthem Blue Cross (California Medi-Cal): GLP-1 Coverage Considerations
“The following GLP-1 drugs are currently on the CDL and will continue to have a Code I diagnosis restriction of type 2 diabetes.”
- 2.Anthem Blue Cross (California Medi-Cal): GLP-1 Coverage Considerations
“Effective January 1, 2026, these drugs will be removed from the CDL and will no longer be eligible for coverage for weight loss or weight-loss indications:”
- 3.Anthem Blue Cross (California Medi-Cal): GLP-1 Coverage Considerations
“Effective January 1, 2026, these drugs will be removed from the CDL and will no longer be eligible for coverage for weight loss or weight-loss indications: ... Wegovy when used for noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) or cardiovascular disease”
- 4.Anthem Blue Cross (California Medi-Cal): GLP-1 Coverage Considerations
“Effective January 1, 2026, these drugs will be removed from the CDL and will no longer be eligible for coverage for weight loss or weight-loss indications: ... Zepbound when used for obstructive sleep apnea (OSA)”
- 5.
- 6.
Related pages
- What insurance covers Wegovy, Zepbound and other GLP-1 medicines?
- Does Medicaid cover Ozempic, Wegovy or Zepbound?
- How to appeal a Wegovy or Zepbound insurance denial
- Cheapest GLP-1 without insurance: Wegovy, Zepbound and the rest
- Appeal letter generator
- Does Blue Cross Blue Shield FEP cover Wegovy, Zepbound and Saxenda?
